Albuterol vs salbutamol
Pro Research Analysisby 
Searched over 200M research papers
Albuterol vs Salbutamol: Drug Names and Global Usage
Albuterol and salbutamol are two names for the same medication, a short-acting beta-2 adrenergic agonist used primarily to treat asthma and other conditions with reversible airway obstruction. "Albuterol" is the name used in the United States, while "salbutamol" is the name used in most other countries. Both refer to the same active compound and are used interchangeably in clinical practice and research Boulton1997Pacifici2015Colice2008+2 MORE.
Clinical Efficacy in Asthma and Airway Diseases
Effectiveness in Acute Asthma
Both albuterol and salbutamol are highly effective bronchodilators for acute asthma management in children and adults. Studies show that inhaled salbutamol (albuterol) is as effective as subcutaneous epinephrine for treating acute asthma in children, with fewer adverse effects and the advantage of being noninvasive . Continuous nebulization and bolus nebulization of albuterol provide similar improvements in lung function for emergency asthma treatment, with both methods being well tolerated .
Use in Pediatric Tonsillectomy
Preoperative administration of inhaled albuterol (salbutamol) significantly reduces the risk of perioperative respiratory adverse events in children undergoing tonsillectomy. Children who received albuterol before surgery had lower rates of bronchospasm, laryngospasm, coughing, and oxygen desaturation compared to those who received placebo Tester2020Von Ungern-Sternberg2019.
Bronchodilator and Antihyperkalemic Effects
Salbutamol (albuterol) is widely used in infants and children for its bronchodilator effects, improving airway resistance and compliance without significant cardiac side effects. It is also used for its antihyperkalemic properties in neonates and young infants .
Pharmacokinetics and Pharmacodynamics
Albuterol (salbutamol) is typically administered as a racemic mixture, but only one enantiomer (the R-enantiomer or levosalbutamol) is responsible for the desired bronchodilator effects. The other enantiomer may contribute to side effects. The R-enantiomer is more potent but is metabolized more efficiently when administered alone Boulton1997Pacifici2015.
Safety and Tolerability
Albuterol (salbutamol) has a highly favorable safety profile, especially when administered by inhalation. Reformulation of inhalers from chlorofluorocarbon (CFC) to hydrofluoroalkane (HFA) propellants has not affected the drug’s efficacy or safety . In clinical trials, inhaled salbutamol is associated with fewer adverse effects compared to injected epinephrine for acute asthma , and nebulized salbutamol does not have significant cardiac side effects in infants .
Additional Uses Beyond Asthma
Salbutamol (albuterol) is also used off-label for certain neuromuscular conditions, where it may improve muscle strength and pulmonary function, though more research is needed to confirm its efficacy in these settings . Both albuterol and salbutamol have been studied for their effects on muscle mass and protein synthesis, but their use for these purposes is not approved in most countries .
Conclusion
Albuterol and salbutamol are the same medication, differing only in name depending on the region. They are effective, safe, and widely used for the treatment of asthma and other airway diseases in both children and adults. Their clinical efficacy, safety, and pharmacological properties are well established, making them the first-line choice for acute relief of bronchospasm and prevention of exercise-induced bronchoconstriction.
Sources and full results
Most relevant research papers on this topic
Salbutamol administered preoperatively to children undergoing tonsillectomy resulted in a significant reduction in rates of respiratory adverse events
Preoperative salbutamol administration significantly reduces respiratory adverse events in children undergoing tonsillectomy under general anesthesia.
Pharmacokinetics and pharmacodynamics of single oral doses of albuterol and its enantiomers in humans
The eutomer of albuterol is more potent than the distomer, but its bioavailability is less than racemate, and its metabolism is more efficient without the distomer.
Effect of Albuterol Premedication vs Placebo on the Occurrence of Respiratory Adverse Events in Children Undergoing Tonsillectomies: The REACT Randomized Clinical Trial.
Albuterol premedication significantly reduces the risk of perioperative respiratory adverse events in children undergoing tonsillectomy compared to placebo.
Bronchodilator and Antihyperkalemic Effects of Salbutamol (Albuterol) in Neonates and Young Infants
Salbutamol is a safe and effective bronchodilator and antihyperkalemic agent for neonates and young infants, improving lung function and reducing resistance in chronic lung diseases.
Inhaled salbutamol (albuterol) vs injected epinephrine in the treatment of acute asthma in children
Inhaled salbutamol and subcutaneous epinephrine are equally effective for treating acute asthma in children, with salbutamol being more noninvasive and having fewer adverse effects.
Albuterol/budesonide for the treatment of exercise-induced bronchoconstriction in patients with asthma: the TYREE study.
A single dose of albuterol/budesonide 180/160 g taken 30 minutes before exercise significantly reduces exercise-induced bronchoconstriction in asthma patients compared to placebo.
DOI